They don't address the root cause
As the inflammatory response progresses, a glial scar is formed around the injury, consisting mostly of proteoglycans and reactive astrocytes
The most defensible rationale for oral BPC-157 is local action in the digestive tract itself
However, individuals with pre-existing health conditions, hormonal disorders, or those taking medications should consult their healthcare provider before starting any peptide therapy
Subcutaneous peptide complex formulations offer a more practical alternative for research protocols, with dosing typically ranging from 50-200 mg per administration
Nausea or Gastrointestinal Upset: Mild queasiness may occur, linked to BPC-157s gastric origins, especially at higher doses